Women’s health landscape shifting, but systemic hurdles remain
It is no secret that research and development (R&D) efforts to improve care in women’s health have long been critically…
Women's Health
-
-
Addressing sexual minority gaps in cervical and breast cancer screening
According to the US Centers for Disease Control and Prevention (CDC), over 43,000 females and 4,000 females died from breast…
-
Risk of death from cervical cancer is now almost zero with HPV vaccine
Cervical cancer can cause death but can be prevented with the human papillomavirus (HPV) vaccine. A recent study in England…
-
Placental abruption could increase risk of cardiovascular disease in women
Cardiovascular disease (CVD) is the leading cause of death globally, with the World Health Organization (WHO) estimating that 19.8 million…
-
Premature menopause associated with 40% heightened risk of coronary heart disease
According to the US Centers for Disease Control and Prevention, heart disease is the leading cause of death in the…
-
Long-term aspirin use is associated with lower ovarian cancer risk
Ovarian cancer is a leading cause of gynaecological cancer mortality worldwide. Early symptoms of ovarian cancer can include decreased appetite,…
-
Clearing the air: investigating the association between breast cancer and air pollution
Breast cancer is the second most common type of cancer in women, according to the Mayo Clinic, and while survival…
-
MSD and Daiichi Sankyo commence Phase III breast cancer therapy trial
MSD and Daiichi Sankyo have initiated the Phase III HERTHENA-Breast04 clinical trial, with the first subject receiving a dose of…
-
Unmet needs in endometriosis: a persistent challenge
The endometriosis therapeutics market continues to face significant unmet needs, primarily due to low diagnosis rates, limited disease awareness, and…
-
Organon discontinues endometriosis drug after Phase II flunk
Organon is terminating development of its endometriosis drug after the Phase II trial failed to show any benefit. The ELENA…
